Airsupra 90/80mcg combines Albuterol (SABA) for rapid bronchodilation and Budesonide (inhaled corticosteroid) to target chronic airway inflammation. This dual mechanism provides a comprehensive approach for treating both acute asthma attacks and managing chronic respiratory conditions such as COPD, ensuring both immediate relief and long-term management.
Airsupra 90/80mcg contains Albuterol (a Short-Acting Beta Agonist - SABA) and Budesonide (an inhaled corticosteroid) as the active ingredients. Albuterol works by rapidly relaxing the muscles in the airways, providing quick relief from bronchospasms, while Budesonide reduces inflammation and mucus production in the airways, addressing the underlying causes of asthma and COPD symptoms. Together, they offer a combined therapeutic effect to manage both acute and chronic respiratory issues.
SIDE EFFECTS:
Common Side Effects:
Nervousness
Tremors
Headache
Palpitations
Rapid heartbeat
Less Common but Serious Side Effects:
Oral thrush with Budesonide use if mouth isn't rinsed post-inhalation
Hoarseness and throat irritation
Bone density reduction with prolonged use of Budesonide
Increased risk of cataracts or glaucoma with long-term use
PRECAUTIONS:
Albuterol Precautions:
Avoid frequent overuse to prevent tachyphylaxis (diminished effectiveness).
Use only as rescue medication for acute bronchospasms.
Budesonide Precautions:
Rinse mouth after every use to prevent oral thrush.
Avoid sudden discontinuation unless directed by a physician.
Patients with other preexisting conditions should consult a physician before using this medication.
USES:
Relief of acute asthma and COPD symptoms.
Prevention of exercise-induced bronchospasm.
Chronic management of inflammation associated with asthma and COPD flare-ups.
BENEFITS:
Quick relief and long-term management for asthma and COPD.
Albuterol acts rapidly to relieve symptoms during acute bronchospasm episodes.
Budesonide targets and reduces airway inflammation and mucus production over time.
Offers combined therapy to prevent complications associated with chronic airway diseases.
twice daily